Patient Association: Myeloma Patients Europe (MPE) (European Union): Difference between revisions
From Beacon
(Created page with "{{forpatients}} Go back to European Union page '''Primary purpose:''' To educate, inform, and support member groups while advocating for the best research, treatment, and care across Europe. '''Cancer areas of interest:''' hasCancerType::C81-C96: Cancers of the blood and immune system. '''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access].") |
No edit summary |
||
| Line 7: | Line 7: | ||
'''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access]. | '''Access to information:''' [https://www.mpeurope.org/about-mpe/ Click here to access]. | ||
{{Blood}} | |||
{{Bone marrow}} | |||
{{Lymph nodes}} | |||
{{Spleen}} | |||
{{Leukemia}} | |||
Revision as of 21:22, 9 September 2024
Go back to European Union page
Primary purpose: To educate, inform, and support member groups while advocating for the best research, treatment, and care across Europe.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system.
Access to information: Click here to access.
